Anaplastiic Gliomas Radiation, Chemotherapy, or Both?

被引:5
作者
Blondin, Nicholas A. [1 ]
Becker, Kevin P. [1 ]
机构
[1] Yale Univ, Dept Neurol, Sch Med, New Haven, CT 06520 USA
关键词
Anaplastic glioma; Anaplastic astrocytoma; Anaplastic oligodendroglioma; Anaplastic oligoastrocytoma; Treatment; THERAPY-ONCOLOGY-GROUP; HIGH-GRADE GLIOMAS; MALIGNANT GLIOMA; PHASE-III; VINCRISTINE PCV; EUROPEAN-ORGANIZATION; PROMOTER METHYLATION; FINAL REPORT; RADIOTHERAPY; TEMOZOLOMIDE;
D O I
10.1016/j.hoc.2012.04.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The optimal treatment of anaplastic gliomas is controversial. Options for treatment include radiation, chemotherapy or a combination of modalities. This article describes how treatment algorithms for anaplastic gliomas have evolved and interprets the results of recent studies. The available evidence indicates that patients can be treated with either chemotherapy or radiation as initial therapy, with use of the other treatment modality at relapse. Whether subpopulations exist for whom one treatment modality is superior to the other at initial diagnosis must be studied prospectively.
引用
收藏
页码:811 / +
页数:14
相关论文
共 67 条
[1]   A MEDICAL-RESEARCH-COUNCIL TRIAL OF 2 RADIOTHERAPY DOSES IN THE TREATMENT OF GRADE-3 AND GRADE-4 ASTROCYTOMA [J].
BLEEHEN, NM ;
STENNING, SP .
BRITISH JOURNAL OF CANCER, 1991, 64 (04) :769-774
[2]   Temozolomide Versus Procarbazine, Lomustine, and Vincristine in Recurrent High-Grade Glioma [J].
Brada, Michael ;
Stenning, Sally ;
Gabe, Rhian ;
Thompson, Lindsay C. ;
Levy, David ;
Rampling, Roy ;
Erridge, Sara ;
Saran, Frank ;
Gattamaneni, Rao ;
Hopkins, Kirsten ;
Beall, Sarah ;
Collins, V. Peter ;
Lee, Siow-Ming .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (30) :4601-4608
[3]   Survival following adjuvant PCV or temozolomide for anaplastic astrocytoma [J].
Brandes, Alba A. ;
Nicolardi, Linda ;
Tosoni, Alicia ;
Gardiman, Marina ;
Iuzzolino, Paolo ;
Ghimenton, Claudio ;
Reni, Michele ;
Rotilio, Antonino ;
Sotti, Guido ;
Ermani, Mario .
NEURO-ONCOLOGY, 2006, 8 (03) :253-260
[4]   Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: A prospective GICNO study [J].
Brandes, Alba A. ;
Tosoni, Alicia ;
Cavallo, Giovanna ;
Reni, Michele ;
Franceschi, Enrico ;
Bonaldi, Laura ;
Bertorelle, Roberta ;
Gardiman, Marina ;
Ghimenton, Claudio ;
Iuzzolino, Paolo ;
Pession, Annalisa ;
Blatt, Valeria ;
Ermani, Mario .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (29) :4746-4753
[5]   Factors influencing survival in high-grade gliomas [J].
Buckner, JC .
SEMINARS IN ONCOLOGY, 2003, 30 (06) :10-14
[6]   CHEMOTHERAPY FOR ANAPLASTIC OLIGODENDROGLIOMA [J].
CAIRNCROSS, G ;
MACDONALD, D ;
LUDWIN, S ;
LEE, D ;
CASCINO, T ;
BUCKNER, J ;
FULTON, D ;
DROPCHO, E ;
STEWART, D ;
SCHOLD, C ;
WAINMAN, N ;
EISENHAUER, E .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (10) :2013-2021
[7]   Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402 [J].
Cairncross, Gregory ;
Berkey, Brian ;
Shaw, Edward ;
Jenkins, Robert ;
Scheithauer, Bernd ;
Brachman, David ;
Buckner, Jan ;
Fink, Karen ;
Souhami, Luis ;
Laperierre, Normand ;
Mehta, Minesh ;
Curran, Walter .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) :2707-2714
[8]   CHEMOTHERAPY FOR OLIGODENDROGLIOMA - PROGRESS REPORT [J].
CAIRNCROSS, JG ;
MACDONALD, DR .
ARCHIVES OF NEUROLOGY, 1991, 48 (02) :225-227
[9]   Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas [J].
Cairncross, JG ;
Ueki, K ;
Zlatescu, MC ;
Lisle, DK ;
Finkelstein, DM ;
Hammond, RR ;
Silver, JS ;
Stark, PC ;
Macdonald, DR ;
Ino, Y ;
Ramsay, DA ;
Louis, DN .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (19) :1473-1479
[10]   Bevacizumab for Recurrent Alkylator-Refractory Anaplastic Oligodendroglioma [J].
Chamberlain, Marc C. ;
Johnston, Sandra .
CANCER, 2009, 115 (08) :1734-1743